I-131

I-131 NCA
Radiochemical Sodium Iodine Solution

Isotope I-131 iodine

Specifications

AVAILABILITY
HALF-LIFE
8,02 days

APPLICATION: Radioiodine has the distinction of being the first theranostic agent in our armamentarium, I-131 being gamma and beta emitter can be used in diagnostic and therapeutic thyroid applications, industrial tracers, and various research applications such as antibody labelling. Iodine-131 is also used to label antibodies for therapeutic applications in the treatment of cancers.
CHARACTERISTICS: 131I as iodide in NaOH solution, The 131I radionuclide radioactive emmition is as follows: Eβ = 0.607 MeV, Eγ = 364 keV. The I-131 we present has proved high quality and level of purity, it is no carrier added.
PROCESS DATA: I-131 is produced by the irradiation of Tellurium-130 in a nuclear reactor.
Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases
Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases
Iodine Symporter Targeting with 124I/131I Theranostics
Iodine Symporter Targeting with 124I/131I Theranostics
	I131 reinforces antitumor activity of metuximab by reversing epithelial–mesenchymal transition via VEGFR‐2 signaling in hepatocellular carcinoma
I131 reinforces antitumor activity of metuximab by reversing epithelial–mesenchymal transition via VEGFR‐2 signaling in hepatocellular carcinoma